These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32074159)

  • 1. The lowdown on low-dose naltrexone.
    Shabeeb N
    Cutis; 2020 Jan; 105(1):E17-E18. PubMed ID: 32074159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Dose Naltrexone in Dermatology.
    Jaros J; Lio P
    J Drugs Dermatol; 2019 Mar; 18(3):235-238. PubMed ID: 30909326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study.
    Raknes G; Småbrekke L
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):136-142. PubMed ID: 27670755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
    Patten DK; Schultz BG; Berlau DJ
    Pharmacotherapy; 2018 Mar; 38(3):382-389. PubMed ID: 29377216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The uses of naltrexone in dermatologic conditions.
    Lee B; Elston DM
    J Am Acad Dermatol; 2019 Jun; 80(6):1746-1752. PubMed ID: 30582992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Naltrexone--high expectations to low dosages].
    Raknes G; Giverhaug T
    Tidsskr Nor Laegeforen; 2011 May; 131(8):844-6. PubMed ID: 21556092
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
    Roginsky G; Alexoff A; Ehrenpreis ED
    J Clin Gastroenterol; 2015 Oct; 49(9):794-5. PubMed ID: 26280708
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose naltrexone for disease prevention and quality of life.
    Brown N; Panksepp J
    Med Hypotheses; 2009 Mar; 72(3):333-7. PubMed ID: 19041189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
    Raknes G; Småbrekke L
    PLoS One; 2019; 14(2):e0212460. PubMed ID: 30763385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
    Turel AP; Oh KH; Zagon IS; McLaughlin PJ
    J Clin Psychopharmacol; 2015 Oct; 35(5):609-11. PubMed ID: 26203498
    [No Abstract]   [Full Text] [Related]  

  • 11. No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study.
    Raknes G; Småbrekke L
    BMC Endocr Disord; 2020 Oct; 20(1):151. PubMed ID: 33004044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

  • 13. A different opinion regarding the use of opiate antagonists in PTSD: comments on "An unusual reaction to opioid blockade with naltrexone in a case of post-traumatic stress disorder".
    Glover H
    J Trauma Stress; 1995 Jul; 8(3):483-9. PubMed ID: 7582612
    [No Abstract]   [Full Text] [Related]  

  • 14. [Low dose naltrexone for treatment of pain].
    Plesner KB; Vægter HB; Handberg G
    Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.
    Younger J; Mackey S
    Pain Med; 2009; 10(4):663-72. PubMed ID: 19453963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label, low-dose naltrexone for refractory chronic low back pain.
    Ghai B; Bansal D; Hota D; Shah CS
    Pain Med; 2014 May; 15(5):883-4. PubMed ID: 24967470
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicolau syndrome following intramuscular naltrexone injection.
    Malik MH; Heaton H; Sloan B
    Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease).
    Ibrahim O; Hogan SR; Vij A; Fernandez AP
    JAMA Dermatol; 2017 Oct; 153(10):1015-1017. PubMed ID: 28768314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled acute dosage naltrexone study in young autistic children.
    Willemsen-Swinkels SH; Buitelaar JK; Weijnen FG; van Engeland H
    Psychiatry Res; 1995 Oct; 58(3):203-15. PubMed ID: 8570776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.